Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · August 24, 2023

Efficacy and Outcomes of Uptitrating Baricitinib Therapy in Patients With Severe Alopecia Areata

JAMA Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Dermatology
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 Trials
JAMA Dermatol 2023 Aug 09;[EPub Ahead of Print], JM Ko, TT Mayo, WF Bergfeld, Y Dutronc, G Yu, SG Ball, N Somani, BG Craiglow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading